针对趋化因子及其受体的靶向治疗能减轻炎症损伤,可望成为一种新的炎症性肠病的治疗方法。
Targeted therapy that aims directly at chemokines and their receptors can ameliorate inflammatory damage, and can be a novel therapeutics for inflammatory bowel disease.
影响着一百万多美国人的炎症性肠病,是指能引起肠部炎症的两种慢性病:克罗恩氏病和溃疡性结肠炎。
Inflammatory bowel disease (IBD), which affects as many as 1 million Americans, refers to two chronic diseases that cause inflammation of the intestines: Crohn's disease and ulcerative colitis.
我研究了下炎症性肠病(IBD),找到了一份更健康的食谱,尤其是一道菜富含纤维,可以缓解症状。
I researched IBD and found that a healthier diet, especially one with higher amounts of fiber, could minimize the symptoms.
用于筛查和诊断肿瘤,息肉(有癌变的可能)和炎症性肠病。
Screening or testing for cancer, polyps (growths that may become cancer), or inflammatory bowel disease.
这里有一些处理压力的办法,也许能帮你控制炎症性肠病。
Here are some ways to handle stress, and maybe keep your IBD nice and quiet.
在这个地区,炎症性肠病的诊断有特别的问题。
虽然可以有其他,更加尖锐,短期内这些症状的原因,当他们变得更加频繁和慢性炎症性肠病(IBD)的诊断需要探索。
While there can be other, more acute and short term causes of these symptoms, when they become more frequent and chronic then the diagnosis of Inflammatory Bowel Disease (IBD) needs to be explored.
炎症性肠病病人接受合适的药物治疗常常延迟,各种当地传统治疗方法被广泛使用。
There is often a delay in using proper medications for IBD, and alternative local remedies are still widely used.
炎症性肠病是一个条件,导致炎症和炎性细胞的浸润肠壁。
Inflammatory Bowel Disease is a condition resulting from an inflammatory condition and an infiltration of the gut wall with inflammatory cells.
炎症性肠病(IBD)是一组反复发作的肠道慢性炎症性疾病,包括溃疡性结肠炎和克罗恩病。
Inflammatory bowel disease (IBD) is chronic recurrent intestinal inflammatory disorders, including ulcerative colitis and Crohn's disease.
目的:研究髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)活性在监测炎症性肠病(IBD)病情活动中的作用。
Objective: to evaluate the monitoring action of the expression myeloperoxidase (MPO) and superoxide dismutase (SOD) activity in the active inflammatory bowel disease (IBD).
炎症性肠病(IBD)的病因和发病机制至今仍未完全明确。
The etiological factors and mechanism of inflammatory bowel disease (IBD) are not clear yet.
克罗恩病和溃疡性结肠炎统称为炎症性肠病(IBD),病因虽不明确,但对其发病机理已有了较多的了解。
Crohn s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), the etiology is not clear, but its pathogenesis has had more understanding.
目的:观察一种新型美沙拉嗪控释剂(艾迪莎)治疗炎症性肠病(IBD)的疗效和安全性,并同水杨酸偶氮磺胺吡啶(SASP)进行比较。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的分析并探讨炎症性肠病(IBD)患者肠外表现的特点和临床意义。
Objective to analyze and examine the characteristics and roles of extra-intestinal manifestations accompanied with inflammatory bowel disease (IBD).
结、直肠癌在老年、中年组的发病率明显高于其他年龄组; 中年组肛周病变、炎症性肠病的发病率明显高于其他年龄组。
The morbidity of large bowel cancer in the elderly and middle-aged groups were obviously higher than that of the other age groups.
此文主要就肠易激综合征和炎症性肠病在发病机制和临床表现上的异同作一阐述。
In this review, we summarize the difference between IBD and IBS on the pathogenesis and clinical manifestation.
目的:了解炎症性肠病药物遗传学的现状,为该类药物在临床的合理应用提供参考。
OBJECTIVE: to investigate status quo of pharmacogenetics of inflammatory bowel disease (IBD), in order to provide some references for rational use of such kinds of drugs in the clinic.
炎症性肠病的病因和发病机制尚不明确,涉及环境、遗传、免疫失调等因素。
The etiology and pathogenesis of inflammatory bowel disease, which is not clear, may involve in many factors such as environment, genetic and immunity dysregulation.
实验动物模型对于发现抗炎症性肠病的药物及探讨其发病机制具有重要作用。
In inflammatory bowel disease, the experimental models have been proven to be important tools to investigate the potential therapeutic agent and to study the mechanism of pathogenesis.
炎症性肠病是一种慢性的、反复发作的、终身性的胃肠道疾病,包括溃疡性结肠炎和克罗恩病。
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease are chronic, life-long, and relapsing diseases of the gastrointestinal tract.
炎症性肠病的妇女尤其是克罗恩病的妇女剖腹产的几率大约是健康的妇女的1.5倍。
Women with IBD were 1.5 times as likely to hae had a caesarean section as their healthy peers, especially those with Crohn's disease.
南京医科大学附属苏州医院郑家驹教授报告《炎症性肠病的流行病学及中国研究概况》。
Nanjing medical university hospital affiliated suzhou ZhengGuJu professor report "inflammatory bowel disease epidemiology and Chinese research situation".
运用益生菌治疗炎症性肠病的证据是什么?
What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
慢性炎症性肠道病的后果免疫系统70%位于肠!
Consequences of chronic inflammatory intestinal disorders 70%of the immune system is located in the intestine!
结论:与未患炎症性肠病的患者相比,患有炎症性肠病的患者复发性VTE风险增加。
CONCLUSIONS: patients with IBD are at an increased risk of recurrent VTE compared to patients without IBD.
综述了与炎症性肠病相关的常见眼部病变的临床表现及治疗原则。
The ocular manifestations and treatments of inflammatory bowel disease were reviewed in the summarized paper.
医生:根据你的检查结果,可以确定你得的是溃疡性结肠炎,属于炎症性肠病的一种,炎症性肠病简称IBD。
Doctor: : According to the results, you're diagnosed as ulcerative colitis, which is one type of inflammatory bowel disease, IBD for short.
结论益生菌对炎症性肠病的治疗是有效的和安全的。
Results It was obviously well on patients′ feeling in treatment …
结论益生菌对炎症性肠病的治疗是有效的和安全的。
Results It was obviously well on patients′ feeling in treatment …
应用推荐